1) 宮本雅之, 宮本智之, 平田幸一. 睡眠時無呼吸症候群. In: 柳澤信夫, 篠原幸人, 岩田 誠, 他編集. Annual Review 神経2002. 東京: 中外医学社; 2002. p. 268- 80
|
|
|
2) The Report of an American Academy of Sleep Medicine Task Force. Sleep-Related Breathing Disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999; 22: 667-89
|
|
|
3) Sleep Related Breathing Disorders. In: American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 2nd ed. Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005. p. 33-77
|
|
|
4) Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342: 1378-84
|
|
|
5) Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163: 19-25
|
|
|
6) Arzt M, Young T, Finn L, et al. Association of Sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005; 172: 1447-51
|
|
|
7) Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005; 353: 2034-41
|
|
|
8) Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046- 53
|
|
|
9) Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006; 37: 2317-21
|
|
|
10) Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. A 10-Year Follow-up. Arch Intern Med. 2008; 168: 297-301
|
|
|
11) Valham F, Mooe T, Rabben T, et al. Increased risk of stroke in patients with coronary artery disease and sleep apnea: 10-year follow-up. Circulation. 2008; 118: 955-60
|
|
|
12) Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008; 31: 1071-8
|
|
|
13) Marshall NS, Wong KKH, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: The Busselton Health Study. Sleep. 2008; 31: 1079-85
|
|
|
14) Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003; 42: 1067-74
|
|
|
15) Goncalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: A case-control study. Chest. 2007; 132: 1858-62
|
|
|
16) Baguet JP, Levy P, Barone-Rochette G, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens. 2008; 26: 885-92
|
|
|
17) Rizzoni D, Porteri E, Platto C, et al. Morning rise of blood pressure and subcutaneous small resistance artery structure. J Hypertens. 2007; 25: 1698-703
|
|
|
18) Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: The strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006; 29: 581-7
|
|
|
19) Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005; 352: 1206-14
|
|
|
20) Robbins J, Redline S, Ervin A, et al. Associations of sleep-disordered breathing and cerebral changes on MRI. J Clin Sleep Med. 2005; 1: 159-65
|
|
|
21) Nishibayashi N, Miyamoto M, Miyamoto T, et al. Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med. 2008; 4: 242-7
|
|
|
22) Ryan S, Taylor C, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005; 112: 2660-7
|
|
|
23) Jelic S, Padeletti M, Kawut S, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008; 117: 2270-8
|
|
|
24) Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax. 2008; 63: 578-83
|
|
|
25) Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intra-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med. 2005; 172: 625-30
|
|
|
26) Taheri S, Austin D, Lin L, et al. Correlates of serum C-reactive protein(CRP)- No association with sleep duration or sleep disordered breathing. Sleep. 2007; 30: 991-6
|
|
|
27) Sharma SK, Mishra HK, Sharma H, et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med. 2008; 9: 149-56
|
|
|
28) Minoguchi K, Yokoe T, Tanaka A, et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J. 2006; 28: 378-85
|
|
|
29) Seicean S, Kirchner HL, Gottlieb DJ, et al. Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals. The Sleep Heart Health Study. Diabetes Care. 2008; 31: 1001-6
|
|
|
30) Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and Type II diabetes: A population-based study. Am J Respir Crit Care Med. 2005; 172: 1590-5
|
|
|
31) West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006; 61: 945-50
|
|
|
32) Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005; 99: 1998-2007
|
|
|
33) Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005; 165: 447-52
|
|
|
34) Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008; 134: 686-92
|
|
|
35) Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Research and Clinical Practice. 2008; 81: 2-12
|
|
|
36) Steiner S, Jax T, Evers S, et al. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology. 2005; 104: 92-6
|
|
|
37) von Kanel, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath. 2006; 10: 139-46
|
|
|
38) Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med. 2007; 175: 612-7
|
|
|
39) Kobayashi K, Nishimura Y, Shimada T, et al. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest. 2006; 129: 632-7
|
|
|
40) Stevenson IH, Teichtahl H, Cunnington D, et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008; 29: 1662-9
|
|
|
41) Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007; 50: 417-23
|
|
|
42) Hsu CY, Vennelle M, Li HY, et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry. 2006; 77: 1143-9
|
|
|
43) Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006; 13: 198-200
|
|
|
44) Larkin EK, Rosen CL, Kirchner HL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation. 2005; 111: 1978-84
|
|
|
45) Amin R, Somers VK, McConnell K, et al. Activity-adjusted 24-Hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008; 51: 84-91
|
|
|